Sutro Biopharma Inc. (STRO)
NASDAQ: STRO
· Real-Time Price · USD
0.88
0.10 (12.81%)
At close: Aug 15, 2025, 3:59 PM
0.88
0.02%
After-hours: Aug 15, 2025, 07:16 PM EDT
Sutro Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 63.74M | 17.4M | 14.81M | 8.52M | 25.71M | 13.01M | 113.72M | 16.92M | 10.41M | 12.67M | 8.63M | 25.15M | 28.1M | 5.9M | 10.65M | 8.52M | 28.05M | 14.66M |
Cost of Revenue | 1.9M | n/a | -1.74M | 1.8M | 1.79M | 1.76M | 1.73M | 434K | 2.4M | 2.26M | 2.16M | 2.08M | 2.05M | 29.99M | 2.4M | 26.6M | 25.31M | 22.56M |
Gross Profit | 61.84M | 17.4M | 12.94M | 8.52M | 23.92M | 11.25M | 111.99M | 16.49M | 8.02M | 10.42M | 6.47M | 23.07M | 26.04M | -24.09M | 8.25M | -18.09M | 2.74M | -7.9M |
Operating Income | -3.35M | -68.51M | -65.26M | -67.92M | -48.69M | -56.59M | 43.15M | -44.01M | -46.18M | -42.24M | -49.22M | -21.21M | -19.38M | -39.13M | -35.04M | -34.67M | -9.8M | -19.01M |
Interest Income | 2.52M | 3.19M | 3.86M | 27.04M | 4.91M | 4.1M | 4.56M | 4.55M | 2.84M | 2.56M | 2.13M | 1.01M | 197K | 116K | 96K | 109K | 175K | 197K |
Pretax Income | -11.52M | -75.97M | -70.09M | -48.79M | -48.01M | -58.21M | 46.87M | -47.45M | -38.37M | -49.66M | -34.59M | -19.49M | -23.51M | -39.11M | -38.13M | -30.9M | -6.15M | -30.36M |
Net Income | -11.5M | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M | 31.07M | -49.28M | -38.52M | -50.05M | -37.09M | -17.77M | -26.01M | -39.09M | -38.13M | -30.9M | -6.15M | -30.36M |
Selling & General & Admin | 10.34M | 13.27M | 9.03M | 14.33M | 12.37M | 10.96M | 15.07M | 15.27M | 15M | 15.51M | 14.72M | 14.64M | 15.14M | 15.04M | 15.76M | 16.59M | 12.54M | 11.11M |
Research & Development | 38.33M | 51.6M | 71.04M | 62.11M | 62.02M | 56.88M | 53.77M | 45.67M | 41.59M | 39.4M | 43.13M | 31.71M | 32.33M | 29.99M | 29.93M | 26.6M | 25.31M | 22.56M |
Other Expenses | -1.9M | 21.04M | -1.87M | n/a | -1.79M | n/a | n/a | -1.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 46.77M | 85.91M | 78.2M | 76.44M | 72.6M | 67.84M | 68.84M | 59.2M | 56.59M | 54.91M | 57.85M | 46.36M | 47.48M | 45.03M | 45.69M | 43.19M | 37.85M | 33.67M |
Interest Expense | 9.65M | 10.64M | 8.69M | 7.91M | 9.04M | 9.4M | 8.73M | 8.68M | 3.36M | 2.99M | n/a | 2.79M | 594K | 657K | 612K | 820K | 847K | 858K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -1.76M | -1.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 48.67M | 85.91M | 80.09M | 76.44M | 74.39M | 69.6M | 70.57M | 60.94M | 56.59M | 54.91M | 57.85M | 46.36M | 47.48M | 45.03M | 45.69M | 43.19M | 37.85M | 33.67M |
Income Tax Expense | -18K | n/a | 2.35M | n/a | 8K | n/a | 15.81M | 1.84M | 151K | 395K | 2.5M | -1.72M | 2.5M | -22K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 84.58M | 83.11M | 82.53M | 82.04M | 81.22M | 61.46M | 61.01M | 60.6M | 60.34M | 58.72M | 56.79M | 52.35M | 46.96M | 46.5M | 46.01M | 46.12M | 46.12M | 45.91M |
Shares Outstanding (Diluted) | 84.58M | 83.11M | 82.53M | 82.04M | 81.22M | 61.46M | 61.01M | 60.6M | 60.34M | 58.72M | 56.79M | 52.35M | 46.96M | 46.5M | 46.16M | 46.16M | 46.12M | 45.91M |
EPS (Basic) | -0.14 | -0.91 | -0.88 | -0.59 | -0.59 | -0.95 | 0.51 | -0.81 | -0.64 | -0.85 | -0.65 | -0.34 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | -0.66 |
EPS (Diluted) | -0.14 | -0.91 | -0.88 | -0.59 | -0.59 | -0.95 | 0.51 | -0.81 | -0.64 | -0.85 | -0.65 | -0.34 | -0.55 | -0.84 | -0.83 | -0.67 | -0.13 | -0.66 |
EBITDA | -3.35M | -63.42M | -59.53M | -39.08M | -38.93M | -49.27M | 54.99M | -39.47M | -35.14M | -46.9M | -32.44M | -14.62M | -20.86M | -36.46M | -35.11M | -25.12M | -4.18M | -28.21M |
EBIT | -1.87M | -47.47M | -61.4M | -40.88M | -40.72M | -51.03M | 50.68M | -41.21M | -37.53M | -46.67M | -35.29M | -16.7M | -22.92M | -38.45M | -37.51M | -30.08M | -5.3M | -29.5M |
Depreciation & Amortization | 1.9M | 1.9M | 1.87M | 1.8M | 1.79M | 1.76M | 1.73M | 1.74M | 2.4M | 2.26M | 2.16M | 2.08M | 2.05M | 2M | 2.4M | 4.96M | 1.12M | 1.29M |